Interestingly, despite AFP being widely recognized as a conventional clinical marker for diagnosing and prognosticating patients with HCC, our study found that it did not independently correlate with prognosis in early-stage HCC following curative hepatectomy. This evidence concerns the gene AFP and hepatocellular carcinoma.